If, like me, you’ve been wondering what the pharmaceutical companies have been doing in response to the terrible events surrounding Ebola, here’s a two minute video from Reuters that offers some useful insight. The video discusses Johnson and Johnson, GSK and some investor perspectives. Apparently JnJ and GSK may collaborate on vaccines, according to the video.
This risk briefing that just came out today on Ebola and the reporting of it is also useful.
I'm Tobias Webb, founder of Innovation Forum and Sustainable Wine. I write on this blog, with others, about areas of interest to me in supply chains, circular economy and sustainability in general. I hope you find it useful. I've worked in sustainability for about 20 years, and work with large companies, NGOs and governments all over the world. I often act as facilitator, at our conferences, and other meetings, either private or multi-stakeholder. I also work as a 'critical friend' advisor to companies on strategy and stakeholder engagement. I have a separate wine website on sustainability in wine at 
